阿司匹林与华法令联合抗凝治疗在急性心肌梗死后二级预防中的地位评价

被引：2

作者：

李世军

李小鹰

机构：

[1] 中国人民解放军总医院南楼心血管一科

来源：

医学综述 | 2009年 / 15卷 / 13期

关键词：

阿司匹林; 华法令; 抗凝; 心肌梗死; 二级预防;

D O I：

暂无

中图分类号：

R542.22 [];

学科分类号：

摘要：

再灌注策略的应用显著降低了急性心肌梗死患者的病死率,心肌梗死后的二级预防对于降低再发心肌梗死的病死率至关重要。目前抗凝治疗在再发心肌梗死中的作用受到越来越多的重视。本文通过对华法令-阿司匹林再梗死研究Ⅱ的解读以及对近年文献的回顾,认为对于有较高卒中和血栓事件危险的患者,口服抗凝药物与阿司匹林联用在心肌梗死二级预防中具有重要地位。

引用

收藏

页码：1972 / 1974

页数：3

相关论文

共 7 条

[1]

Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy [J].

Jaumdally, R ;

Lip, GYH ;

Varma, C .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (09) :1070-1081

[2]

Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study [J].

DiMarco, JP ;

Flaker, G ;

Waldo, AL ;

Corley, SD ;

Greene, HL ;

Safford, RE ;

Rosenfeld, LE ;

Mitrani, G ;

Nemeth, M .

AMERICAN HEART JOURNAL, 2005, 149 (04) :650-656

[3]

Acute coronary syndromes: Virchow's triad revisited [J].

Lee, KW ;

Lip, GYH .

BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (07) :605-625

[4]

Oral ximelagatran for secondary prophylaxis after myocardial infarction:: the ESTEEM randomised controlled trial [J].

Wallentin, L ;

Wilcox, RG ;

Weaver, WD ;

Emanuelsson, H ;

Goodvin, A ;

Nyström, P ;

Bylock, A .

LANCET, 2003, 362 (9386) :789-797

[5]

Oral anticoagulation after myocardial infarction [J].

Arnesen, H .

THROMBOSIS RESEARCH, 2003, 109 (04) :163-170

[6]

Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997 - The Minnesota Heart Survey [J].

McGovern, PG ;

Jacobs, DR ;

Shahar, E ;

Arnett, DK ;

Folsom, AR ;

Blackburn, H ;

Luepker, RV .

CIRCULATION, 2001, 104 (01) :19-24

[7]

Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment [J].

Avidor, Y ;

Nadu, A ;

Matzkin, H .

UROLOGY, 2000, 55 (01) :22-24